2003 studies found for:    breast,cancer,treatment | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy
Condition: Locally Recurrent/Metastatic Triple Negative Breast Cancer
Interventions: Radiation: external beam radiation therapy;   Drug: cisplatin;   Procedure: Biopsy of Target Tumor
22 Not yet recruiting Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
Conditions: Hormone Receptor Positive Malignant Neoplasm of Breast;   Human Epidermal Growth Factor 2 Negative Carcinoma of Breast;   Estrogen Receptor Positive Breast Cancer;   Progesterone Receptor Positive Tumor;   Metastatic Breast Cancer
Interventions: Drug: Palbociclib;   Drug: Tamoxifen
23 Unknown  ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer
Conditions: Breast Cancer;   Breast Disease;   Neoplasms;   Neoplasms by Site
Intervention: Drug: cyclophosphamide, Adriamycin, Docetaxel, Trastuzumab, Zolendronic acid
24 Not yet recruiting Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer
Conditions: Estrogen Receptor Positive;   Postmenopausal;   Stage 0 Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer
Interventions: Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Other: Placebo;   Other: Quality-of-Life Assessment;   Procedure: Therapeutic Conventional Surgery
25 Recruiting Phase II Window of Opportunity Study of Short-term Preoperative Treatment With Enzalutamide (Alone or in Combination With Exemestane) in Patients With Primary Breast Cancer
Conditions: Primary Breast Cancer ER+ve;   Primary Breast Cancer AR+ve TNBN
Interventions: Drug: Enzalutamide;   Drug: Exemestane
26 Recruiting Omitting Completion Axillary Treatment in Sentinel Node Positive Breast Cancer Patients Undergoing a Mastectomy
Condition: Breast Neoplasms
Intervention: Procedure: Completion axillary treatment
27 Recruiting Intraoperative Radiation Therapy in Early Stage Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: Intraoperative Radiation Therapy
28 Recruiting Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer
Conditions: Malignant Neoplasm of Breast;   Breast Cancer
Interventions: Drug: Genomically Directed Monotherapy;   Other: Observation/Standard Therapy
29 Recruiting Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
Conditions: Invasive Breast Cancer (Stage I-III);   Ductal Carcinoma in Situ;   Lobular Carcinoma in Situ;   Lobular Carcinoma;   Fatigue Related to Cancer Treatment
Interventions: Drug: Naltrexone;   Drug: Sugar Pill
30 Recruiting Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart
Conditions: Breast Cancer;   Adverse Effect of Radiation Therapy
Intervention: Radiation: Radiation therapy
31 Recruiting IMAGE Study: Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins
Condition: Metastatic Breast Cancer
Intervention: Other: Treatment suggestion
32 Unknown  Fatigue in Breast Cancer Survivors
Conditions: Breast Cancer;   Cancer Survivor;   Fatigue;   Psychosocial Effects of Cancer and Its Treatment
Interventions: Genetic: protein analysis;   Other: laboratory biomarker analysis;   Other: mass spectrometry;   Other: questionnaire administration;   Procedure: assessment of therapy complications;   Procedure: cognitive assessment;   Procedure: quality-of-life assessment
33 Recruiting Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors
Condition: Breast Cancer
Interventions: Device: Focused Microwave Thermotherapy;   Drug: Chemotherapy (control)
34 Recruiting Paclitaxel and Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Patients With Previously Untreated Stage I-III Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   HER2-positive Breast Cancer;   Progesterone Receptor-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage IA Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Triple-negative Breast Cancer
Interventions: Drug: paclitaxel;   Drug: cyclophosphamide;   Biological: trastuzumab;   Procedure: therapeutic conventional surgery;   Radiation: radiation therapy;   Drug: doxorubicin hydrochloride;   Other: laboratory biomarker analysis
35 Recruiting Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast Cancer
Conditions: Musculoskeletal Complication;   Recurrent Breast Carcinoma;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Therapy-Related Toxicity
Interventions: Procedure: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Other: Medical Chart Review
36 Recruiting Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer
Conditions: Dyspnea;   Fatigue;   Nausea and Vomiting;   Pain;   Stage IV Breast Cancer
Interventions: Radiation: Stereotactic Radiosurgery;   Procedure: Therapeutic Conventional Surgery;   Other: Laboratory Biomarker Analysis
37 Not yet recruiting Breast Cancer Lung Late Effects
Conditions: Radiation Injury;   Breast Cancer
Interventions: Radiation: Proton beam radiation therapy.;   Radiation: X-ray based radiation therapy;   Procedure: Computed Tomography (CT) Scan;   Procedure: Pulmonary Function Test (PFT)
38 Not yet recruiting Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
Conditions: Breast Cancer;   Early Stage;   Triple Negative Breast Cancer
Interventions: Drug: Enzalutamide;   Behavioral: assessment
39 Recruiting Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer
Conditions: Male Breast Carcinoma;   Prostate Adenocarcinoma;   Recurrent Breast Carcinoma;   Recurrent Non-Small Cell Lung Carcinoma;   Recurrent Prostate Carcinoma;   Stage IV Breast Cancer;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Prostate Cancer
Intervention: Radiation: Stereotactic Radiosurgery
40 Unknown  "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"
Conditions: Infiltrating Duct and Lobular Carcinoma In Situ;   Invasive Lobular Breast Carcinoma;   Inflammatory Breast Carcinoma
Intervention: Drug: Docetaxel, Epirubicin, Cyclophosphamide/Navelbine, Capecitabine, Trastuzumab, Bevacizumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years